Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19

Alberca, Ricardo Wesley; Andrade, Milena Mary de Souza; Branco, Ana Cláudia Calvielli Castelo; Pietrobon, Anna Julia; Pereira, Nátalia  Zanete; Fernandes, Iara Grigoletto; Oliveira, Luana de mendonça; Teixeira, Franciane Mouradian Emidio; Beserra, Danielle Rosa; Oliveira, Emily Araujo de; Silva, Sarah Cristina Gozzi; Ramos, Yasmim Álefe Leuzzi; Brito, Cyro Alves de; Arnone, Marcelo; Orfali, Raquel Leao; Aoki, Valeria; Duarte, Alberto Jose da Silva; Sarto, Maria Notomi

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19

Alberca, Ricardo Wesley; Andrade, Milena Mary de Souza; Branco, Ana Cláudia Calvielli Castelo; Pietrobon, Anna Julia; Pereira, Nátalia Zanete; Fernandes, Iara Grigoletto; Oliveira, Luana de mendonça; Teixeira, Franciane Mouradian Emidio; Beserra, Danielle Rosa; Oliveira, Emily Araujo de; Silva, Sarah Cristina Gozzi; Ramos, Yasmim Álefe Leuzzi; Brito, Cyro Alves de; Arnone, Marcelo; Orfali, Raquel Leao; Aoki, Valeria; Duarte, Alberto Jose da Silva; Sarto, Maria Notomi.

Front.med.; 7 (), 2020

Ano de publicação: 2020

Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+CD33+HLA-DR-CD14+ cells and CD11b+CD33+HLA-DR-CD66b+ cells.

Febre, Coronavirus, Sangue, Antígenos HLA-DR

Texto completo